<DOC>
	<DOCNO>NCT03102840</DOCNO>
	<brief_summary>Streptococcus pneumoniae type bacteria carry ( life ) nose individual sometimes go cause severe infection meningitis pneumonia . There 100 type pneumococcus , child UK routinely immunize pneumococcal disease since 2006 . A vaccine 13 type pneumococcus ( PCV 13 ) introduce UK 2010 , replace previous version prevent 7 type . Pneumococcal carriage Thames Valley region study last 7 year carriage rate show reflective potential severe pneumococcal disease hence vaccine effect . The main purpose study see whether pneumococcal immunization program change frequency nature pneumococcal bacteria carry child , may give u clue change pneumococcal disease likely see future . In addition , study especially timely give possibility change PCV 13 immunization schedule currently assess 'Sched3 ' Immunization study ( NCT02482636 ) . Obtaining accurate baseline data important inform interpretation subsequent data carriage rate obtain follow introduction new schedule . This study enroll approximately 1600 child age 13 48 month live Thames Valley South Midlands three dose 13-valent pneumococcal conjugate vaccine . The study consist one visit do convenient venue ( GP surgery , educational/ play setting , home ) single nasal swab optional finger-prick blood sample sub-set XXX ( define ) participant , perform . No additional follow-up need . The study recruitment period do 12 month .</brief_summary>
	<brief_title>Understanding Pneumococcal Carriage Disease 2017/2018</brief_title>
	<detailed_description>This cross sectional observational study determine point prevalence pneumococcal carriage child . In study approximately 1600 , healthy child age 13-48 month receive complete course PCV13 least one month prior study enrollment , recruit . The study carry Thames Valley South Midlands . Parents/legal guardian approach either website base advertisement , social medium , poster advertisement email and/or hand information booklet child 's nursery , GP Surgeries educational/play setting . We may also identify potential participant mail invitation letter leaflets age appropriate child via Open Exeter system National Health Application Infrastructure Services , Child Health Computer Department , equivalent NHS database Clinical Research Network . Parents/legal guardians potential participant express interest direct Oxford Vaccine group ( OVG ) website able access participant information booklet appropriate complete online self-screening . If parent approach OVG express interest , information booklet sent may telephone screen . This study involve one visit . The study visit arrange occur convenient venue : hospital patient , university clinic room , village hall , church hall , nursery , participant 's home , sport recreational area , GP practice similar venue pre-school child frequently attend . We would seek permission venue carry study procedure premise . We pre-arranged date time parents/legal guardian plan attend online booking , phone call email . During visit would go detail study provide opportunity question . For willing proceed would ask sign consent form collect demographic information . A nasopharyngeal swab take , consent optional blood sample perform subset XXX ( confirm ) participant . No visits follow-up require .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Pneumonia , Pneumococcal</mesh_term>
	<criteria>1 . Parent/guardian participant willing able give inform consent participation study . 2 . In good health determine brief medical history and/or clinical judgement investigator . 3 . Have receive three dos PCV13 per infant immunization schedule ( confirm red book vaccination history age ) . Vaccination history confirm child 's GP CHCD . The visit sampling may still proceed vaccination history confirm beforehand participant subsequently exclude find receive three dos PCV13 . 4 . Aged 1348 month least 28 day since third PCV13 vaccination . 5 . Able ( Investigators opinion ) willing comply study requirement . 1 . Parent/legal guardian unwilling unable give write informed consent participate study . 2 . Parent/legal guardian less 18 year age time enrollment . 3 . Parent/legal guardian list study delegation log . 4 . Children known unimmunized incomplete course PCV13 . 5 . Any significant disease disorder , opinion Investigator , may either put participant risk participation study , may influence result study , participant 's ability participate study . 6 . History bleed disorder . Temporary exclusion criterion : 1 . Febrile illness temperature 38Â°C day visit precede 24 hour . 2 . Respiratory illness day study visit precede 24 hour . A respiratory illness classify combination least two follow symptom : cough , sore throat , runny nose . 3 . Administration antibiotic month prior sample . 4 . History acute nose bleed ( within last 24 hour ) , recent ( within last 3 month ) nasal/craniofacial surgery . 5 . Receipt blood product and/or plasma derivative parenteral immunoglobulin preparation within 90 day .</criteria>
	<gender>All</gender>
	<minimum_age>13 Months</minimum_age>
	<maximum_age>48 Months</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Carriage</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Pneumococcal conjugate vaccine 13 ( PCV 13 )</keyword>
	<keyword>Children</keyword>
	<keyword>Pneumococcus</keyword>
</DOC>